HistoSonics

Last updated: July 21, 2024

Mike Blue - President, CEO
Mike Blue - President, CEO
USA | Funding: $226.8M (+)

Website: http://www.histosonics.com/

HistoSonics is developing a non-invasive, autonomous robotic platform capable of destroying tissue at a sub-cellular level.